| [1] |
Iliskovic N,Singal PK.Lipid lowering:an important factor in preventing adriamycin-induced heart failure[J].Am J Pathol,1997,150(2):727.
|
| [2] |
From AM,Maleszewski JJ,Rihal CS.Current status of endomyocardial biopsy[C].Mayo Clin Proc,2011,86(11):1095-1102.
|
| [3] |
Gharib MI,Burnett AK.Chemotherapy-induced cardiotoxicity:current practice and prospects of prophylaxis[J].Eur J Heart Failure,2002,4(3):235-242.
|
| [4] |
Ky B,French B,Levy WC,et al.Multiple biomarkers for risk prediction in chronic heart failure[J].Circ:Heart Failure,2012,5(2):183-190.
|
| [5] |
Zethelius B,Berglund L,Sundström J,et al.Use of multiple biomarkers to improve the prediction of death from cardiovascular causes[J].N Engl J Med,2008,358(20):2107-2116.
|
| [6] |
Fertin M, Dubois E, Belliard A, et al. Usefulness of circulating biomarkers for the prediction of left ventricular remodeling after myocardial infarction[J].Am J Cardiol,2012,110(2):277-283.
|
| [7] |
Granados-Principal S,Quiles JL,Ramirez-Tortosa CL,et al.New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients[J].Food Chem Toxicol,2010,48(6):1425-1438.
|
| [8] |
Oemrawsingh RM,Lenderink T,Akkerhuis KM,et al.Multimarker risk model containing troponin-T,interleukin 10,myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome[J].Heart,2011,97(13):1061-1066.
|
| [9] |
He H,Wang S,Li X,et al.A novel metabolic balance model for describing the metabolic disruption of and interactions between cardiovascular-related markers during acute myocardial infarction[J].Metabolism,2013,62(10):1357-1366.
|
| [10] |
Dai LL,Wan HT,Zhou HF,et al.Protective effect of Guhonginjection on rat cerebral microvascular endothelial cells injured by oxygen glucose deprivation[J].Chin Pharm J(中国药学杂志),2014,49(21):1897-1902.
|
| [11] |
Wang J,Jiang Z,Ji J,et al.Evaluation of hepatotoxicity and cholestasis in rats treated with EtOH extract of Fructus Psoraleae[J].J Ethnopharmacol,2012,144(1):73-81.
|
| [12] |
Cheng K,Mao S,Zhou Y.Detection of nitric oxide in patients with herpes simplex keratitis by the method of nitric acid reductase[J].Foreign Med Sci(国外医学),2005,26(10):675-677.
|
| [13] |
Hasi'c S,Hadovi'c-Duvo A,Jadri'c R,et al.B-type natriuretic peptide and adiponectin releases in rat model of myocardial damage induced by isoproterenol administration[J].Bosn J Basic Med Sci,2013,13(4):225-229.
|
| [14] |
Li T,Danelisen I,Belló-Klein A,et al.Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats[J].Cardiovasc Res,2000,46(3):523-530.
|
| [15] |
Fadillioglu E,Yılmaz HR,Erdogan H,et al.The activities of tissue xanthine oxidase and adenosine deaminase and the levels of hydroxyproline and nitric oxide in rat hearts subjected to doxorubicin:protective effect of erdosteine[J].Toxicology,2003,191(2):153-158.
|
| [16] |
Saavedra WF,Paolocci N,John MES,et al.Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart[J].Circ Res,2002,90(3):297-304.
|
| [17] |
Liu B,Li H,Qu H,et al.Nitric oxide synthase expressions in ADR-induced cardiomyopathy in rats[J].J Biochem Mol Biol,2006,39(6):759.
|
| [18] |
Weinstein DM,Mihm MJ,Bauer JA.Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice[J].J Pharmacol Exp Ther,2000,294(1):396-401.
|
| [19] |
Wang TJ,Larson MG,Levy D,et al.Plasma natriuretic peptide levels and the risk of cardiovascular events and death[J].N Engl J Med,2004,350(7):655-663.
|
| [20] |
Feola M,Garrone O,Occelli M,et al.Cardiotoxicity after anthracycline chemotherapy in breast carcinoma:effects on left ventricular ejection fraction,troponin I and brain natriuretic peptide[J].Int J Cardiol,2011,148(2):194-198.
|
下载:
